Compare Recursion Pharmaceuticals Inc (RXRX) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Spotify Technology — how do they compare? Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B), while Spotify Technology trades at $501.85 (market cap $103.00B). The key difference: Spotify Technology is far larger — about 56.9× Recursion Pharmaceuticals Inc's market cap, and Spotify Technology is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | SPOT | |
|---|---|---|
Market Cap | $1.81B | $103.00B |
Sector | Health | Media |
52-Week High | $6.79 | $738.53 |
52-Week Low | $2.84 | $412.75 |
Enterprise Value | $1.33B | $92.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
